Age, and not comorbidity, is associated with adjuvant chemotherapy use in older breast cancer patients in England

被引:0
|
作者
Richards, Paul [1 ]
Ward, Sue [1 ]
Morgan, Jenna [2 ]
Francis, Matthew [3 ]
Lawrence, Gill [3 ]
Wyld, Lynda [2 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Sheffield, Acad Unit Surg Oncol, Sheffield S10 2TN, S Yorkshire, England
[3] Publ Hlth England, Knowledge & Intelligence Team West Midlands, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P13
引用
收藏
页码:20 / 21
页数:2
相关论文
共 50 条
  • [21] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Hurria, A
    Brogan, K
    Panageas, KS
    Pearce, C
    Norton, L
    Jakubowski, A
    Zauderer, M
    Howard, J
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 151 - 156
  • [22] Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer
    Kimmick, Gretchen G.
    Li, Xiangrong
    Fleming, Steven T.
    Sabatino, Susan A.
    Wilson, J. Frank
    Lipscomb, Joseph
    Cress, Rosemary
    Bergom, Carmen
    Anderson, Roger T.
    Wu, Xiao-Cheng
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 214 - 220
  • [23] Adjuvant chemotherapy in breast cancer: assessment of age
    Nature Clinical Practice Oncology, 2005, 2 (5): : 226 - 227
  • [24] Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
    Dalmasso, Bruna
    Hatse, Sigrid
    Brouwers, Barbara
    Laenen, Annouschka
    Berben, Lieze
    Kenis, Cindy
    Smeets, Ann
    Neven, Patrick
    Schoeffski, Patrick
    Wildiers, Hans
    BMC CANCER, 2018, 18
  • [25] Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
    Bruna Dalmasso
    Sigrid Hatse
    Barbara Brouwers
    Annouschka Laenen
    Lieze Berben
    Cindy Kenis
    Ann Smeets
    Patrick Neven
    Patrick Schöffski
    Hans Wildiers
    BMC Cancer, 18
  • [26] Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer
    NIGUMA, K. U. M. I.
    MAMISHIN, K. A. N. A. K. O.
    NAITO, Y. O. I. C. H. I.
    NOMURA, S. H. O. G. O.
    WAKABAYASHI, M. A. S. A. S. H. I.
    KUSUHARA, S. H. O. T. A.
    FUNASAKA, C. H. I. K. A. K. O.
    NAKAO, T. A. K. E. H. I. R. O.
    FUKASAWA, Y. O. K. O.
    KONDOH, C. H. I. H. I. R. O.
    HARANO, K. E. N. I. C. H. I.
    KOGAWA, T. A. K. A. H. I. R.
    MATSUBARA, N. O. B. U. A. K., I
    HOSONO, A. K. O.
    ONISHI, T. A. T. S. U. Y. A.
    KAWASAKI, T. O. S. H. I. K. A. T. S. U.
    MUKOHARA, T. O. R. U.
    ANTICANCER RESEARCH, 2022, 42 (07) : 3743 - 3751
  • [27] Adjuvant Chemotherapy in Older Women With Early Breast Cancer
    Trapani, Dario
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1652 - +
  • [28] AN UPDATE OF THE TOLERABILITY AND FEASIBILITY OF NEWER ADJUVANT CHEMOTHERAPY IN OLDER PATIENTS WITH BREAST CANCER
    Pathmanathan, Shivanshan
    Ladwa, Rahul
    Sanmugarajah, Jasotha
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 130 - 130
  • [29] Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?
    Freedman, Rachel A.
    Winer, Eric P.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (06): : 551 - 552
  • [30] Impact of adjuvant chemotherapy on clinical and biological ageing in older breast cancer patients
    Brouwers, Barbara
    Hatse, Sigrid
    Dal Lago, Lissandra
    Neven, Patrick
    Vuylsteke, Peter
    Debrock, Guy
    Van den Bulck, Heidi
    Smeets, Ann
    Bechter, Oliver
    Swerts, Evalien
    Bailur, Jithendra Kini
    Kenis, Cindy
    Laenen, Annouschka
    Dalmasso, Bruna
    Schoffski, Patrick
    Pawelec, Graham
    Wildiers, Hans
    CANCER RESEARCH, 2015, 75